Careers

Post-doctoral Researchers

Nanoparticles for brain tumours and neurodegenerative diseases (MSCA Expression of interest)

Back

Brief description of the Centre/Research Group:

Molecular materials are uniquely placed to spur a revolution in the next decades, thanks to their ability to accommodate a wide span of functionalities, and the possibility to fine-tune them to suit a variety of technological purposes. However, while these materials already show optimal behaviour either in solution, as single crystals or as microcrystalline powders, their integration into functional devices still poses a scientific challenge, since once incorporated into solid matrices or hybrid devices, they often lose (at least partially) their inherent properties and/or their response efficiency.

Our objective at the Nanostructured Functional Materials research group (NANOSFUN) is to develop new strategies for obtaining molecular (bio)nanostructures with adapted properties and smart responses to external stimuli, which can be incorporated into solid matrices, surfaces or as stable colloidal suspensions, while retaining their initial properties and performance. For this, a wide range of molecular and biological building blocks are used, using Nature a strong source of inspiration. We work with the idea that ultimate control on every length scale and interface is required to reach the intrinsic limits and functions of these (supra)molecular materials, with their future introduction in our everyday life in sight.

Project description:

The objective of this project is to develop frontier research at the cross border between Neuroscience and Nanotechnology. More precisely, we aim to understand the role of catecholamine-based (and their intermediates) nanostructures created within the Central Nervous System (CNS) and the role they play in Neurodegenerative diseases via metal induced aggregation, ROS effect of radical polymerization.

More in detail, the work would be devoted to the treatment of some of the previously studied alterations with nanocarriers, mostly based on metal-organic and/or mesoporous silica nanoparticles. Work will include the design and fabrication of theranostics nanoplatforms for the controlled released of drugs together with tissue imaging.

Applications:

All applications must be sent to Dani Ruiz (dani.ruiz@icn2.cat) and include the following:

  • A full CV including contact details.
  • Motivation letter.
  • 2 recommendation letters.

Deadline for applications: 30th June 2018